The development of ADAM10 endocytosis inhibitors for the treatment of Alzheimer's disease.
Musardo S, Therin S, Pelucchi S, D'Andrea L, Stringhi R, Ribeiro A, Manca A, Balducci C, Pagano J, Sala C, Verpelli C, Grieco V, Edefonti V, Forloni G, Gardoni F, Meli G, Di Marino D, Di Luca M, Marcello E.
Musardo S, et al.
Mol Ther. 2022 Jul 6;30(7):2474-2490. doi: 10.1016/j.ymthe.2022.03.024. Epub 2022 Apr 4.
Mol Ther. 2022.
PMID: 35390543
Free PMC article.